Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1 is a research paper published in Nature Medicine (2022). On theSindex it has a DataRank of 7.8. It has been cited 450 times, with 200 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.917
From this paper's citation signal
Citation Network Contribution
6.9
From 200 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 200 citers.
Melanoma Research Foundation
Grant: Melanoma Breakthrough Foundation Breakthrough Consortium 2020
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Grant: R01 CA257265
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Grant: P50 CA254865
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Grant: R01 CA228181
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Grant: R01 CA222203
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Grant: P50 CA254865)
NCI NIH HHS
Grant: P30 CA047904
National Institutes of Health
Grant: 5P50CA254865-02
Melanoma and Skin Cancer Program SPORE
National Institutes of Health
Grant: 1R01CA257265-01
Neoadjuvant Immunotherapy with Intratumoral CPG and PD-1 Blockade in Melanoma
National Institutes of Health
Grant: 5R01CA222203-03
Fecal Microbiota Transplant and PD-1 blockade in Melanoma
National Institutes of Health
Grant: 5R01CA228181-03
Targeting TIGIT and PD-1 in Melanoma
National Institutes of Health
Grant: 3P30CA047904-07S1
CANCER CENTER SUPPORT GRANT
FWCI
30.43
Citation Percentile
1.0%
Influential Citations
20
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Molecular mimicry between tumor associated antigens and microbiota-derived epitopes
Additional file 1 of Molecular mimicry between tumor associated antigens and microbiota-derived epitopes
Additional file 1 of Univariable and multivariable Mendelian randomization study identified the key role of gut microbiota in immunotherapeutic toxicity
Additional file 1 of Univariable and multivariable Mendelian randomization study identified the key role of gut microbiota in immunotherapeutic toxicity
Additional file 2 of Univariable and multivariable Mendelian randomization study identified the key role of gut microbiota in immunotherapeutic toxicity
Additional file 2 of Univariable and multivariable Mendelian randomization study identified the key role of gut microbiota in immunotherapeutic toxicity
Additional file 2 of Gut microbiome for predicting immune checkpoint blockade-associated adverse events
Additional file 1 of Gut microbiome for predicting immune checkpoint blockade-associated adverse events
Additional file 1 of Gut microbiome for predicting immune checkpoint blockade-associated adverse events
Additional file 2 of Gut microbiome for predicting immune checkpoint blockade-associated adverse events